MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Nov 21, 2025 · CIK: 1878313
| Field | Detail |
|---|---|
| Company | Maia Biotechnology, INC. (MAIA) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
MAIA Bio filed an 8-K on Nov 21, 2025. Details TBD.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on November 21, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements, only that they were reported on this date.
Why It Matters
This filing indicates that MAIA Biotechnology, Inc. has made a regulatory submission, but the content of the filing requires further review to understand its implications.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate disclosed material events, making the immediate risk low.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- November 21, 2025 (date) — Filing Date
FAQ
What specific 'Other Events' are being reported by MAIA Biotechnology, Inc. in this 8-K filing?
The filing states 'Other Events' as an item, but does not specify the nature of these events within the provided text.
What are the key details of the 'Financial Statements and Exhibits' mentioned in the filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content or details of these financial statements and exhibits are not provided in the excerpt.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is November 21, 2025.
What is the principal executive office address for MAIA Biotechnology, Inc.?
The principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the telephone number for MAIA Biotechnology, Inc.?
The registrant's telephone number, including area code, is (312) 416-8592.
Filing Stats: 769 words · 3 min read · ~3 pages · Grade level 14.4 · Accepted 2025-11-21 09:15:24
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 18KB
- 0001493152-25-024556.txt ( ) — 260KB
- maia-20251121.xsd (EX-101.SCH) — 3KB
- maia-20251121_lab.xml (EX-101.LAB) — 33KB
- maia-20251121_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 21, 2025 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer 3